Cullin-3 protein expression levels correlate with breast cancer progression

Cancer Biology and Therapy

Volumn 13, Issue 11, 2012, Pages 1042-1046

  Haagenson, Kelly K ^a,b   Tait, Larry ^a   Wang, Juan ^a   Shekhar, Malathy P ^a,b   Polin, Lisa ^a   Chen, Wei ^a,b   Wu, Gen Sheng ^a,b  

^a KARMANOS CANCER INSTITUTE   (United States)

^b WAYNE STATE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Breast cancer; Cullin 3; DCIS; Tumor progression; Ubiquitin proteasome pathway

Indexed keywords

CULLIN; CULLIN 3; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; ASSAY; CANCER GROWTH; CANCER STAGING; CONTROLLED STUDY; DISEASE MARKER; DISEASE SEVERITY; FEMALE; GENE OVEREXPRESSION; HUMAN; HUMAN TISSUE; INTRADUCTAL CARCINOMA; LUNG METASTASIS; MOUSE; NONHUMAN; PROTEIN ANALYSIS; PROTEIN EXPRESSION; PROTEIN FUNCTION; STAINING; TUMOR XENOGRAFT;

ANIMALS; BREAST NEOPLASMS; CARCINOMA, DUCTAL, BREAST; CELL LINE, TUMOR; CULLIN PROTEINS; DISEASE PROGRESSION; FEMALE; HUMANS; IMMUNOHISTOCHEMISTRY; LUNG NEOPLASMS; MICE; MICE, NUDE; NEOPLASM STAGING; PROGNOSIS; TRANSPLANTATION, HETEROLOGOUS; TUMOR MARKERS, BIOLOGICAL;

EID: 84865849343     PISSN: 15384047     EISSN: 15558576     Source Type: Journal    
DOI: 10.4161/cbt.21046     Document Type: Article

References (23)

1. Siegel R, Ward E, Brawley O, Jemal A. Cancer statistics: the impact of eliminating socioeconomic and racial disparities on premature cancer deaths. CA Cancer J Clin 2011; 61:212-36; PMID:21685461; http://dx.doi.org/10.3322/caac. 20121.
2. Kuerer HM, Albarracin CT, Yang WT, Cardiff RD, Brewster AM, Symmans WF, et al. Ductal carcinoma in situ: state of the science and roadmap to advance the field. J Clin Oncol 2009; 27:279-88; PMID:19064970; http://dx.doi.org/10.1200/ JCO.2008.18.3103.
3. Jemal A, Siegel R, Ward E, Hao Y, Xu J, Murray T, et al. Cancer statistics. CA Cancer J Clin 2008; 58:71-96; PMID:18287387; http://dx.doi.org/ 10.3322/CA.2007.0010.
4. Erbas B, Provenzano E, Armes J, Gertig D. The natural history of ductal carcinoma in situ of the breast: a review. Breast Cancer Res Treat 2006; 97:135-44; PMID:16319971; http://dx.doi.org/10.1007/s10549-005-9101-z.
5. Hershko A, Ciechanover A. The ubiquitin system. Annu Rev Biochem 1998; 67:425-79; PMID:9759494; http://dx.doi.org/10.1146/annurev.biochem.67.1.425.
6. Petroski MD, Deshaies RJ. Function and regulation of cullin-RING ubiquitin ligases. Nat Rev Mol Cell Biol 2005; 6:9-20; PMID:15688063; http://dx.doi.org/10.1038/nrm1547.
7. Geyer R, Wee S, Anderson S, Yates J, Wolf DA. BTB/POZ domain proteins are putative substrate adaptors for cullin 3 ubiquitin ligases. Mol Cell 2003; 12:783-90; PMID:14527422; http://dx.doi.org/10.1016/S1097-2765(03)00341-1.
8. Bosu DR, Kipreos ET. Cullin-RING ubiquitin ligases: global regulation and activation cycles. Cell Div 2008; 3:7; PMID:18282298; http://dx.doi.org/10. 1186/1747-1028-3-7.
9. Furukawa M, He YJ, Borchers C, Xiong Y. Targeting of protein ubiquitination by BTB-Cullin 3-Roc1 ubiquitin ligases. Nat Cell Biol 2003; 5:1001-7; PMID:14528312; http://dx.doi.org/10.1038/ncb1056.
10. Pintard L, Willis JH, Willems A, Johnson JL, Srayko M, Kurz T, et al. The BTB protein MEL-26 is a substrate-specific adaptor of the CUL-3 ubiquitin-ligase. Nature 2003; 425:311-6; PMID:13679921; http://dx.doi.org/10. 1038/nature01959.
11. Xu L, Wei Y, Reboul J, Vaglio P, Shin TH, Vidal M, et al. BTB proteins are substrate-specific adaptors in an SCF-like modular ubiquitin ligase containing CUL-3. Nature 2003; 425:316-21; PMID:13679922; http://dx.doi.org/10. 1038/nature01985.
12. Chen LC, Manjeshwar S, Lu Y, Moore D, Ljung BM, Kuo WL, et al. The human homologue for the Caenorhabditis elegans cul-4 gene is amplified and overexpressed in primary breast cancers. Cancer Res 1998; 58:3677-83; PMID:9721878.
13. Guardavaccaro D, Pagano M. Oncogenic aberrations of cullin-dependent ubiquitin ligases. Oncogene 2004; 23:2037-49; PMID:15021891; http://dx.doi.org/10.1038/sj.onc.1207413.
14. Loignon M, Miao W, Hu L, Bier A, Bismar TA, Scrivens PJ, et al. Cul3 overexpression depletes Nrf2 in breast cancer and is associated with sensitivity to carcinogens, to oxidative stress, and to chemotherapy. Mol Cancer Ther 2009; 8:2432-40; PMID:19638449; http://dx.doi.org/10.1158/1535-7163.MCT-08-1186.
15. Nioi P, Nguyen T. A mutation of Keap1 found in breast cancer impairs its ability to repress Nrf2 activity. Biochem Biophys Res Commun 2007; 362:816-21; PMID:17822677; http://dx.doi.org/10.1016/j.bbrc.2007.08.051.
16. Wilkins A, Ping Q, Carpenter CL. RhoBTB2 is a substrate of the mammalian Cul3 ubiquitin ligase complex. Genes Dev 2004; 18:856-61; PMID:15107402; http://dx.doi.org/10.1101/gad.1177904.
17. Miller FR, Soule HD, Tait L, Pauley RJ, Wolman SR, Dawson PJ, et al. Xenograft model of progressive human proliferative breast disease. J Natl Cancer Inst 1993; 85:1725-32; PMID:8411256; http://dx.doi.org/10.1093/jnci/85.21.1725.
18. Miller FR, Santner SJ, Tait L, Dawson PJ. MCF10DCIS.com xenograft model of human comedo ductal carcinoma in situ. J Natl Cancer Inst 2000; 92:1185-6; PMID:10904098; http://dx.doi.org/10.1093/jnci/92.14.1185A.
19. Tait LR, Pauley RJ, Santner SJ, Heppner GH, Heng HH, Rak JW, et al. Dynamic stromal-epithelial interactions during progression of MCF10DCIS. com xenografts. Int J Cancer 2007; 120:2127-34; PMID:17266026; http://dx.doi.org/10. 1002/ijc.22572.
20. Santner SJ, Dawson PJ, Tait L, Soule HD, Eliason J, Mohamed AN, et al. Malignant MCF10CA1 cell lines derived from premalignant human breast epithelial MCF10AT cells. Breast Cancer Res Treat 2001; 65:101-10; PMID:11261825; http://dx.doi.org/10.1023/A:1006461422273.
21. Armitage P, Berry G, Matthews JNS. Statistical Methods in Medical Research. Oxford: Blackwell Science 2002; 4:506.
22. R Development Core Team. R: A language and environment for statistical computing. R Foundation for Statistical Computing, Vienna, Austria 2001. ISBN 3-900051-07-0; http://www.R-project.org/.
23. Shekhar MP, Tait L, Pauley RJ, Wu GS, Santner SJ, Nangia-Makker P, et al. Comedo-ductal carcinoma in situ: A paradoxical role for programmed cell death. Cancer Biol Ther 2008; 7:1774-82; PMID:18787417; http://dx.doi.org/10.4161/cbt. 7.11.6781.